跳至主要内容
临床试验/NCT00857064
NCT00857064已完成不适用

Subjective Well Being of Schizophrenic Patients in Greece

AstraZeneca1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
600
试验地点
1
主要终点
Assessment of Subjective well being

研究概览

简要总结

Non-interventional study aiming to provide data on the subjective effects of antipsychotic medication assessing subjective well-being and global functioning of patients with Schizophrenia under antipsychotic medication. Moreover it aims to assess their adherence to the treatment and will investigate whether there is any correlation of these factors with the clinical condition of these patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of written informed consent
  • Diagnosis of schizophrenia according to DSM-IV
  • The patient must have been prescribed an atypical antipsychotic for at least 4 weeks before the first study visit

排除标准

  • 未提供

结局指标

主要结局

Assessment of Subjective well being

时间窗: Relative score reported in SWBN scale at the visit. No baseline comparison

Assessment of functioning

时间窗: Relative score reported in GAF scale at the visit. No baseline comparison

次要结局

  • Assessment of Compliance to therapy(Relative score reported in BARS scale at the visit. No baseline comparison)
  • Assessment of General Psychopathology(Relative score reported in PANNS scale at the visit. No baseline comparison)
  • Assessment of Clinical Condition(Relative score reported in CGIS scale at the visit. No baseline comparison)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Subjective Well Being of Schizophrenic Patients in... | 临床试验